Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

Health Finance and Policy

TWENTY-SECOND MEETING

2021-2022 Regular Session - March 02, 2021

STATE OF MINNESOTA TWENTY-SECOND MEETING
HOUSE OF REPRESENTATIVES NINETY-SECOND SESSION

HEALTH FINANCE AND POLICY COMMITTEE

MINUTES

Representative Tina Liebling, Chair of the Committee, called the virtual Health Finance and Policy Committee meeting to order at 3:00 P.M. on March 2, 2021 pursuant to House rule 10.01. The meeting is being broadcast via Zoom and House Public Information Services.

The Committee Legislative Assistant noted the roll.

Members present:
LIEBLING, Tina, Chair
HUOT, John, Vice Chair
SCHOMACKER, Joe, Minority Lead
AKLAND, Susan
BACKER, Jeff
BAHNER, Kristin
BIERMAN, Robert
BOLDON, Liz
DEMUTH, Lisa
FREIBERG, Mike
GRUENHAGEN, Glenn
KIEL, Debra
MORRISION, Kelly
MUNSON, Jeremy
PRYOR, Laurie
QUAM, Duane
REYER, Liz
SCHULTZ, Jennifer
WOLGAMOTT, Dan

A quorum was present.

Representative Quam moved that the minutes of March 1, 2021 be approved. THE MOTION PREVAILED.

Dave Greeman, Budget Director, Minnesota Department of Human Services (DHS), gave an update on the DHS budget forecast.

HF1183 (Stephenson) First Engrossment Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.

Chair Liebling moved that HF1183 First Engrossment be recommended to pass and be re-referred to the Committee on State Government Finance and Elections.

Chair Liebling moved the H1183A3 Amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Representative Stephenson presented his bill.

Testifying:
1. Dawn Burnfin, SEIU Healthcare Minnesota
2. Brett Michelin, Association for Accessible Medicines

Chair Liebling renewed her motion that HF1183, First Engrossment, be recommended to pass, as amended, and be re-referred to the Committee on State Government Finance and Elections.

Chair Liebling stated there would be a roll call vote. The results were as follows:

AYE
LIEBLING, Tina
HUOT, John
BAHNER, Kristin
BIERMAN, Robert
BOLDON, Liz
FREIBERG, Mike
MORRISON, Kelly
PRYOR, Laurie
REYER, Liz
SCHULTZ, Jennifer
WOLGAMOTT, Dan

NAY
SCHOMACKER, Joe
AKLAND, Susan
BACKER, Jeff
DEMUTH, Lisa
GRUENHAGEN, Glenn
KIEL, Debra
MUNSON, Jeremy
QUAM, Duane

On a vote of 11 AYES and 8 NAYS THE MOTION PREVAILED.

HF1339 (Pinto) Income and asset payments excluded for purposes of determining or redetermining eligibility for economic assistance and health care programs, and report required.

Chair Liebling moved that HF1339 be heard and laid over for possible inclusion in the Health Finance and Policy Committee bill.

Chair Liebling moved the H1339A1 amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Representative Pinto presented his bill.

Testifying:
1. Muneer Karcher-Ramos, Director. City of Saint Paul (Minnesota) Office of Financial Empowerment
2. Kasey Wiedrich, Financial Capability Program Manager, Office of Financial Empowerment, City of Saint Paul

Andrew Abruzzese, Policy Specialist, DHS, Responded to member questions.

Chair Liebling laid over HF1339, as amended, for possible inclusion in the Committee bill.

HF521 (Morrison) Income and asset payments excluded for purposes of determining or redetermining eligibility for economic assistance and health care programs, and report required.

Representative Freiberg moved to adopt the Preventative Health Division Report on HF521. THE MOTION PREVAILED AND THE DIVISION REPORT WAS ADOPTED.

Representative Morrison moved that HF521 be heard and laid over for possible inclusion in the Health Finance and Policy Committee bill.

Representative Morrison moved the H0521A1 amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.

Representative Morrison presented her bill.

Doug Berg, House Fiscal Analyst, Gena Savage, Health Care Policy Analyst, DHS, and Sara Orange, Budget and Finance Director, Health Care Administration, DHS, responded to member questions.

Chair Liebling laid over HF521, as amended, for possible inclusion in the Committee bill.

The meeting was adjourned at 4:26 P.M.


________________________________________________________
Representative Tina Liebling, Chair


________________________________________________________
Krysta Niedernhöfer, Committee Legislative Assistant
More Info On This Meeting..
Bills Added:
  • HF1183 (Stephenson) - Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.
  • HF1339 (Pinto) - Income and asset payments excluded for purposes of determining or redetermining eligibility for economic assistance and health care programs, and report required.
  • HF521 (Morrison) - Medical assistance postpartum coverage extended.
House TV Video:
View Archive

02:47 Health and human services budget forecast update.
22:23 HF1183 (Stephenson) Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify attorney general of prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers; civil penalties imposed; and money appropriated.
50:45 HF1339 (Pinto) Income and asset payments excluded for purposes of determining or redetermining eligibility for economic assistance and health care programs, and report required.
1:03:21 HF521 (Morrison) Medical assistance postpartum coverage extended.



HHS Budget Forecast Update
HF1183 (Stephenson) Drug manufacturer or wholesale distributor prohibited from charging unconscionable prices for prescription drugs; Board of Pharmacy, commissioner of human services, and health plan companies required to notify attorney general of prescription drug price increases; attorney general authorized to take action against drug manufacturers and wholesalers; civil penalties imposed; and money appropriated.
H. F. 1339 (Pinto) Income and asset payments excluded for purposes of determining or redetermining eligibility for economic assistance and health care programs, and report required.
HF521 (Morrison) Medical assistance postpartum coverage extended. (BILL ADDED)

Agenda items may be added/removed.

Members of the public interested in testifying on should email Patrick McQuillan at Patrick.McQuillan@house.mn by 3 pm on Monday, March 1st. Testimony will be limited to two minutes per person. Written testimony will be accepted.

This meeting will be held in accordance with House Rule 10.01, which may be viewed here: https://www.house.leg.state.mn.us/comm/docs/HmNgjtZ_KkKBF3cKO2DXmw.pdf

Public Viewing Information:
This remote hearing will be live-streamed via the House webcast schedule page: https://www.house.leg.state.mn.us/htv/schedule.asp

NOTE: Channels HTV 1 and HTV 2 will provide live closed captioning. Video archives of meetings streamed on HTV 3, 4, and 5 will have closed captions added. Other reasonable accessibility accommodations may be made with advance notice.

Meeting documents will be posted on the House Health Finance and Policy Committee website at https://www.house.leg.state.mn.us/Committees/Home/92011.

If you have questions about the accessibility of remote hearings or require an accommodation, please contact Jenny Nash at: jenny.nash@house.mn or by leaving a message at 651-296-4122. For other questions, please contact Patrick McQuillan (patrick.mcquillan@house.mn).

The MN House of Representatives is currently working on establishing the processes and technology that allow remote meetings to be held that are accessible to the public. Thank you for your patience as we adapt.